Jeremy H Pettus (Jeremy Pettus)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 34

Top Topics

Cardiovascular Disease

Randomized Controlled Trial

Glycemic Control

Roux En Y Gastric Bypass

Top Venues

Diabetes, obesity & metabolism

Nature medicine

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Robert L Thomas, Schafer C Boeder, Vala Hamidi, Erin R Giovannetti, Justin M Gregory, Jeremy H Pettus
Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes. Diabetes care 47 (5) (2024)
Schafer C Boeder, Robert L Thomas, Melissa J Le Roux, Erin R Giovannetti, Justin M Gregory, Jeremy H Pettus
Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial. Diabetes care (2024)
Vala Hamidi, Jeremy H Pettus
Time in Tight Range for Patients With Type 1 Diabetes: The Time Is Now, or Is It Too Soon? Diabetes care 47 (5) (2024)
Jennifer L Sherr, Lori M B Laffel, Jingwen Liu, Wendy Wolf, Jeoffrey Bispham, Katherine S Chapman, Daniel Finan, Lina Titievsky, Tina Liu, Kaitlin Hagan, Jason Gaglia, Keval Chandarana, Richard M Bergenstal, Jeremy H Pettus
Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional Survey. Diabetes care 47 (6) (2024)
Benjamin H Han, Jeremy H Pettus, Kevin H Yang, Alison A Moore, Joseph J Palamar
Past-Month Cannabis Use Among Adults With Diabetes in the U.S., 2021-2022. Diabetes care 47 (9) (2024)
Jennifer L Sherr, Lori M B Laffel, Jingwen Liu, Wendy Wolf, Jeoffrey Bispham, Katherine S Chapman, Daniel Finan, Lina Titievsky, Tina Liu, Kaitlin Hagan, Jason Gaglia, Keval Chandarana, Richard M Bergenstal, Jeremy H Pettus
Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional Survey. Diabetes care 47 (6) (2024)
Jennifer L Sherr, Lori M B Laffel, Jingwen Liu, Wendy Wolf, Jeoffrey Bispham, Katherine S Chapman, Daniel Finan, Lina Titievsky, Tina Liu, Kaitlin Hagan, Jason Gaglia, Keval Chandarana, Richard M Bergenstal, Jeremy H Pettus
Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional Survey. Diabetes care 47 (6) (2024)
Benjamin H Han, Jeremy H Pettus, Kevin H Yang, Alison A Moore, Joseph J Palamar
Past-Month Cannabis Use Among Adults With Diabetes in the U.S., 2021-2022. Diabetes care (2024)
Robert L Thomas, Schafer C Boeder, Vala Hamidi, Erin R Giovannetti, Justin M Gregory, Jeremy H Pettus
Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes. Diabetes care (2024)
Anne Costanzo, Don Clarke, Marie Holt, Siddhartha Sharma, Kenna Nagy, Xuqian Tan, Lisa Kain, Brian Abe, Sandrine Luce, Christian Boitard, Tine Wyseure, Laurent O Mosnier, Andrew I Su, Catherine Grimes, Neal K Devaraj, Paul B Savage, Michael Gottschalk, Jeremy H Pettus, Luc Teyton
Repositioning the Early Pathology of Type 1 Diabetes to the Extraislet Vasculature. Journal of immunology (Baltimore, Md. : 1950) (2024)
Robert L Thomas, Schafer C Boeder, Vala Hamidi, Erin R Giovannetti, Justin M Gregory, Jeremy H Pettus
Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes. Diabetes care 47 (5) (2024)
Robert L Thomas, Schafer C Boeder, Vala Hamidi, Erin R Giovannetti, Justin M Gregory, Jeremy H Pettus
Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes. Diabetes care (2024)
Jennifer L Sherr, Lori M B Laffel, Jingwen Liu, Wendy Wolf, Jeoffrey Bispham, Katherine S Chapman, Daniel Finan, Lina Titievsky, Tina Liu, Kaitlin Hagan, Jason Gaglia, Keval Chandarana, Richard M Bergenstal, Jeremy H Pettus
Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional Survey. Diabetes care 47 (6) (2024)
Benjamin H Han, Jeremy H Pettus, Kevin H Yang, Alison A Moore, Joseph J Palamar
Past-Month Cannabis Use Among Adults With Diabetes in the U.S., 2021-2022. Diabetes care (2024)
Anne Costanzo, Don Clarke, Marie Holt, Siddhartha Sharma, Kenna Nagy, Xuqian Tan, Lisa Kain, Brian Abe, Sandrine Luce, Christian Boitard, Tine Wyseure, Laurent O Mosnier, Andrew I Su, Catherine Grimes, Neal K Devaraj, Paul B Savage, Michael Gottschalk, Jeremy H Pettus, Luc Teyton
Repositioning the Early Pathology of Type 1 Diabetes to the Extraislet Vasculature. Journal of immunology (Baltimore, Md. : 1950) 212 (7) (2024)
Robert L Thomas, Schafer C Boeder, Vala Hamidi, Erin R Giovannetti, Justin M Gregory, Jeremy H Pettus
Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes. Diabetes care 47 (5) (2024)
Jennifer L Sherr, Lori M B Laffel, Jingwen Liu, Wendy Wolf, Jeoffrey Bispham, Katherine S Chapman, Daniel Finan, Lina Titievsky, Tina Liu, Kaitlin Hagan, Jason Gaglia, Keval Chandarana, Richard M Bergenstal, Jeremy H Pettus
Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-Sectional Survey. Diabetes care (2024)
Benjamin H Han, Jeremy H Pettus, Kevin H Yang, Alison A Moore, Joseph J Palamar
Past-Month Cannabis Use Among Adults With Diabetes in the U.S., 2021-2022. Diabetes care 47 (9) (2024)
Steven E Kahn, Cheryl A M Anderson, John B Buse, Elizabeth Selvin, Sonia Y Angell, Vanita R Aroda, Alice Y Y Cheng, Thomas P A Danne, Justin Basile Echouffo-Tcheugui, Stephanie L Fitzpatrick, Meghana D Gadgil, Francesco Rubino, Anna L Gloyn, Jennifer B Green, Ania M Jastreboff, Alka M Kanaya, Namratha R Kandula, Csaba P Kovesdy, Neda Laiteerapong, Kristen J Nadeau, Jeremy H Pettus, Pradipta R Ray, Jennifer E Posey, Camille E Powe, Casey M Rebholz, Michael R Rickels, Naveed Sattar, Jonathan Edward Shaw, Emily K Sims, Kristina M Utzschneider, Adrian Vella, Cuilin Zhang
Reflecting on a Year at the Helm of Diabetes Care. Diabetes care 47 (1) (2023)
Siddhartha Sharma, Xuqian Tan, Josh Boyer, Don Clarke, Anne Costanzo, Brian Abe, Lisa Kain, Marie Holt, Adrienne Armstrong, Marynette Rihanek, Andrew I Su, Cate Speake, Peter A Gottlieb, Michael Gottschalk, Jeremy H Pettus, Luc Teyton
Measuring anti-islet autoimmunity in mouse and human by profiling peripheral blood antigen-specific CD4 T cells. Science translational medicine 15 (703) (2023)
Steven E Kahn, Cheryl A M Anderson, John B Buse, Elizabeth Selvin, Sonia Y Angell, Vanita R Aroda, Alice Y Y Cheng, Thomas P A Danne, Justin Basile Echouffo-Tcheugui, Stephanie L Fitzpatrick, Meghana D Gadgil, Francesco Rubino, Anna L Gloyn, Jennifer B Green, Ania M Jastreboff, Alka M Kanaya, Namratha R Kandula, Csaba P Kovesdy, Neda Laiteerapong, Kristen J Nadeau, Jeremy H Pettus, Pradipta R Ray, Jennifer E Posey, Camille E Powe, Casey M Rebholz, Michael R Rickels, Naveed Sattar, Jonathan Edward Shaw, Emily K Sims, Kristina M Utzschneider, Adrian Vella, Cuilin Zhang
Reflecting on a Year at the Helm of Diabetes Care. Diabetes care 47 (1) (2023)
Jeremy H Pettus, Schafer C Boeder, Mark P Christiansen, Douglas S Denham, Timothy S Bailey, Halis Kaan Akturk, Leslie J Klaff, Julio Rosenstock, Mickie H M Cheng, Bruce W Bode, Edgar D Bautista, Ren Xu, Hai Yan, Dung Thai, Satish K Garg, Samuel Klein
Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nature medicine (2023)
Jeremy H Pettus, Schafer C Boeder, Mark P Christiansen, Douglas S Denham, Timothy S Bailey, Halis Kaan Akturk, Leslie J Klaff, Julio Rosenstock, Mickie H M Cheng, Bruce W Bode, Edgar D Bautista, Ren Xu, Hai Yan, Dung Thai, Satish K Garg, Samuel Klein
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nature medicine 28 (10) (2022)
Richard I G Holt, J Hans DeVries, Amy Hess-Fischl, Irl B Hirsch, M Sue Kirkman, Tomasz Klupa, Barbara Ludwig, Kirsten Nørgaard, Jeremy H Pettus, Pr Eric Renard, Jay S Skyler, Frank J Snoek, Tracey D Brown, Anne L Peters
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes care 44 (11) (2021)
Jeremy H Pettus, Neil Skolnik
Importance of diabetes management during the COVID-19 pandemic. Postgraduate medicine 133 (8) (2021)
Thomas P A Danne, Satish Garg, Anne L Peters, John B Buse, Chantal Mathieu, Jeremy H Pettus, Charles M Alexander, Tadej Battelino, F Javier Ampudia-Blasco, Bruce W Bode, Bertrand Cariou, Kelly L Close, Paresh Dandona, Sanjoy Dutta, Eleuterio Ferrannini, Spiros Fourlanos, George Grunberger, Simon R Heller, Robert R Henry, Martin J Kurian, Jake A Kushner, Tal Oron, Christopher G Parkin, Thomas R Pieber, Helena W Rodbard, Desmond Schatz, Jay S Skyler, William V Tamborlane, Koutaro Yokote, Moshe Phillip
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors. Diabetes care 42 (6) (2019)
Jeremy H Pettus, Jasvinder Gill, Sachin Paranjape, John Stewart, Shilpy Malla, Steven V Edelman, Richard M Bergenstal, Bruce Bode
Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring. Diabetes, obesity & metabolism 21 (8) (2019)
Jeremy H Pettus, Fang Liz Zhou, Leah Shepherd, Ronald Preblick, Phillip R Hunt, Sachin Paranjape, Kellee M Miller, Steven V Edelman
Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study. Diabetes care 42 (12) (2019)
Jeremy H Pettus, Fang Liz Zhou, Leah Shepherd, Katie Mercaldi, Ronald Preblick, Phillip R Hunt, Sachin Paranjape, Kellee M Miller, Steven V Edelman
Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real-world study of more than 30 000 patients in a US electronic health record database. Diabetes, obesity & metabolism 22 (4) (2019)
Steven V Edelman, Nicholas B Argento, Jeremy H Pettus, Irl B Hirsch
Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring. Diabetes care 41 (11) (2019)
Jeremy H Pettus, David D'Alessio, Juan Pablo Frias, Eric G Vajda, James D Pipkin, Julio Rosenstock, Gretchen Williamson, Miriam A Zangmeister, Lin Zhi, Keith B Marschke
Efficacy and Safety of the Glucagon Receptor Antagonist RVT-1502 in Type 2 Diabetes Uncontrolled on Metformin Monotherapy: A 12-Week Dose-Ranging Study. Diabetes care 43 (1) (2019)
Kenneth Cusi, Fernando Bril, Diana Barb, David C Polidori, Sue Sha, Atalanta Ghosh, Kristin Farrell, Nishanth E Sunny, Srilaxmi Kalavalapalli, Jeremy H Pettus, Theodore P Ciaraldi, Sunder Mudaliar, Robert R Henry
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes. Diabetes, obesity & metabolism 21 (4) (2018)
Jeremy H Pettus, Dominic Reeds, Tricia S Cavaiola, Schafer Boeder, Michelle Levin, Garry Tobin, Edda Cava, Dung Thai, Jim Shi, Hai Yan, Edgar Bautista, John McMillan, Roger Unger, Robert R Henry, Samuel Klein
Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trial. Diabetes, obesity & metabolism 20 (5) (2018)
Jeremy H Pettus, Matthias Von Herrath
The shifting paradigm of a "cure" for type 1 diabetes: is technology replacing immune-based therapies? Acta diabetologica 55 (2) (2017)